332 filings
Page 2 of 17
8-K
r22q6
16 Feb 24
Results of Operations and Financial Condition
5:00pm
8-K
m62ghw2 3qpx13
15 Feb 24
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
4:47pm
8-K
qm5kezix j1
5 Jan 24
Departure of Directors or Certain Officers
4:00pm
8-K/A
lj61ug oz9dwfjpw
24 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
NT 10-Q
g78ejv3ksxgc3y
15 Nov 23
Notice of late quarterly filing
12:00am
8-K
8gu913p8514knvdd4h
1 Nov 23
Other Events
9:08am
8-K
tarflmyv
25 Oct 23
T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
9:02am
8-K
gyv7vucq4 r3or
23 Oct 23
Entry into a Material Definitive Agreement
9:00am
8-K
dtn yzb5193y9sivw9y
17 Oct 23
Results of Operations and Financial Condition
4:31pm
8-K
p2r4fd
12 Oct 23
T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
4:32pm
8-K
uhv1l3 716x
12 Oct 23
Material Modifications to Rights of Security Holders
4:01pm
8-K
qe8p 9unjdb
18 Sep 23
Departure of Directors or Certain Officers
5:03pm
EFFECT
1c7ru8tfkyx1o
18 Sep 23
Notice of effectiveness
12:15am
CORRESP
6l3 7czoal19
13 Sep 23
Correspondence with SEC
12:00am
DEFA14A
z01ppn7qc
12 Sep 23
Additional proxy soliciting materials
7:25am
CORRESP
gg2kf hax
11 Sep 23
Correspondence with SEC
12:00am
UPLOAD
1bohe
31 Aug 23
Letter from SEC
12:00am